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Introductory Remarks:
Conference on Pollutants and High Risk
Groups
by D. S. Barth*
In the language and intent of the various laws
which EPA implements, Congress has mandated
that we consider the issues ofthe biological basis of
hypersusceptibility to pollution. For example, the
Clean Air Act Amendments of 1970 require EPA to
set ambient air quality standards to protect the pub-
lic health with a margin of safety, including protec-
tion of particularly susceptible groups within the
population such as asthmatics and bronchitics.
Consequently, EPA's air pollution epidemiological
research has focused heavily on relating acute or
chronic symptoms in asthmatics, the aging, and
other specially susceptible population groups to
measured air pollution exposure levels. Symptoms
in hypersusceptibles may provide early sentinels of
more serious illness in the most sensitive population
groups. Such symptoms also often predict that
higher levels of exposure-or continued exposure
to low levels-will lead to symptoms in much larger
proportions of the general population.
Additional EPA legislation, such as the 1972
Amendment to the Federal Insecticide Fungicide
and Rodenticide Act and the Toxic Substances
Control Act of 1976, require EPA to assess the
health risks of chemicals so that these may be bal-
anced against their benefits. A risk estimate implies
the need to know the impact ofadverse effects of a
chemical on entire exposed populations. Such risk
estimation demands that we step back from the
homogeneous animal strains which we have used to
determine effects of chemicals in order to consider
the whole range of effects of chemicals on the ge-
netically varied, multiple-exposed species which is
modern man.
The most meaningful program to assess the health
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effects of chemicals requires a balance of
epidemiology, clinical research, animal toxicology,
and in vitro studies. This is because each of these
techniques had advantages and limitations which
the others lack. Our focus at this conference places
the emphasis on clinical research and epidemiology
to examine those persons especially sensitive to en-
vironmental chemicals. Hopefully, such an em-
phasis will lead to the development ofbetter animal
and in vitro systems for detecting those levels of
chemicals which will cause illness in susceptible
groups before they are introduced into the human
environment and can cause disease.
Since the banning of DDT, there has been great
enthusiasm with the notion that action can and
should be taken based on animal studies without
having to first show frank disease in people as a
prerequisite to the institution of environmental
controls. What the chemical regulatory agencies
must always keep in mind, however, is that only
close contact with the clinical researcher and
epidemiologist will permit them to identify and
abate the toxic hazards which laboratory investiga-
tions fail to screen out. This is still true even when
we are consciously attempting to select animal and
cellular screens which are highly susceptible to the
hazards which we suspect.
Traditionally, regulatory agencies have focused
upon those groups in which hypersusceptibility
could be demonstrated pathologically and
physiologically, such as patients with cancer and
congenital abnormalities. But in the last decade,
both the Occupational Health and Safety Act of
1970 and the Toxic Substances Control Act of 1976
emphasize a need for research and testing of the
effects of chemicals on behavior in the absence of
demonstrated cellular or biochemical abnormalities.
The limited time available has forced the planners
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important causes of pollution-induced hypersus-
ceptibility. Perhaps the major causes of hypersus-
ceptibility are still unknown or just beginning to
emerge. Nevertheless, a program has been assem-
bled which broadly covers some of the well
documented causes of hypersusceptibility to en-
vironmental chemicals. Hopefully, this meeting will
serve to stimulate further research and several fu-
ture scientific discussions which will cover these
and additional facets of hypersusceptibility in
greater depth.
In the final session, we will see how high risk
groups are being considered in the standards setting
process. We hope to learn how to improve the man-
ner in which this is being done, with subsequent
impacts on the thinking of the public, their rep-
resentatives, government, unions, and industry.
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